Review



transfection control pcmv mir  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    OriGene transfection control pcmv mir
    Transfection Control Pcmv Mir, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 242 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcmv+mir+control/PCMVMIR+MicroRNA+Expression+Vector/pmc10235687-93-11-14
    Average 95 stars, based on 242 article reviews
    transfection control pcmv mir - by Bioz Stars, 2026-10
    95/100 stars

    Images

    Related Articles

    Transfection:

    Article Title: Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer
    Article Snippet: The pancreatic cancer cell line MiaPaCa was maintained at 37°C in a humified atmosphere of 5% CO2 and 95% air in Dulbecco’s modified Eagle Medium (Life Technologies, Inc, Darmstadt, Germany). .. The cells were transfected with Lipofectamine2000 (Life Technologies, Inc, Darmstadt, Germany) according to the manufacturer’s protocol with either PCMV-MIR-802 or PCMV-MIR-Control (OriGene, Rockville, USA). .. MiRNA was extracted from MiaPaCa cells with the miRNeasy Mini Kit (Qiagen, Hilden, Germany).

    Article Title: MicroRNA-133a-1 regulates inflammasome activation through uncoupling protein-2
    Article Snippet: .. After 24 hours , the medium was replaced by serum-free RPMI-1640 and cells were transfected with 2.5μg/well DNA of pCMV-miR control (OriGene, Rockville, MD) and miR-133a-1 (Origene) plasmid using Lipofectamine® LTX plus Reagent (Invitrogen, CA, USA) as per manufacturer instructions. ..

    Control:

    Article Title: MicroRNA-133a-1 regulates inflammasome activation through uncoupling protein-2
    Article Snippet: .. After 24 hours , the medium was replaced by serum-free RPMI-1640 and cells were transfected with 2.5μg/well DNA of pCMV-miR control (OriGene, Rockville, MD) and miR-133a-1 (Origene) plasmid using Lipofectamine® LTX plus Reagent (Invitrogen, CA, USA) as per manufacturer instructions. ..

    Plasmid Preparation:

    Article Title: MicroRNA-133a-1 regulates inflammasome activation through uncoupling protein-2
    Article Snippet: .. After 24 hours , the medium was replaced by serum-free RPMI-1640 and cells were transfected with 2.5μg/well DNA of pCMV-miR control (OriGene, Rockville, MD) and miR-133a-1 (Origene) plasmid using Lipofectamine® LTX plus Reagent (Invitrogen, CA, USA) as per manufacturer instructions. ..



    Similar Products

    95
    OriGene transfection control pcmv mir
    Transfection Control Pcmv Mir, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcmv+mir+control/PCMVMIR+MicroRNA+Expression+Vector/pmc10235687-93-11-14
    Average 95 stars, based on 1 article reviews
    transfection control pcmv mir - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    90
    OriGene pcmv mir control vector
    Pcmv Mir Control Vector, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcmv+mir+control/MIR2053+Human+MicroRNA+Expression+Plasmid/pm34057012-40-6-10
    Average 90 stars, based on 1 article reviews
    pcmv mir control vector - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    OriGene pcmv-mir control microrna overexpression vectors
    a. Experimental procedure for miFAST. Biotinylated miRNA mimics are transfected into cell cultures, and cellular lysates are isolated and separated into total input RNA and pull-down groups. Using IFAST, mRNAs associated with Bi-miR-340 and the RISC complex are extracted and RNA is prepared for analysis. b. Venn diagram of microarray datasets combined to determine high-confidence miR-340 targets in melanoma. Blue circle: mRNAs upregulated obtained from miR-340 inhibition experiments. Red circle: mRNAs downregulated from miR-340 <t>overexpression.</t> Green circle: mRNAs that directly interact with miR-340 identified from Bi-miR-340 experiments. In the center are overlapping targets from each of the datasets in bold, which are considered high-confidence direct miR340 targets.
    Pcmv Mir Control Microrna Overexpression Vectors, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcmv+mir+control/pcmv+mir+vectors/pmc08858646-52-33-38
    Average 90 stars, based on 1 article reviews
    pcmv-mir control microrna overexpression vectors - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    95
    OriGene pcmv mir control microrna overexpression vectors
    a. Experimental procedure for miFAST. Biotinylated miRNA mimics are transfected into cell cultures, and cellular lysates are isolated and separated into total input RNA and pull-down groups. Using IFAST, mRNAs associated with Bi-miR-340 and the RISC complex are extracted and RNA is prepared for analysis. b. Venn diagram of microarray datasets combined to determine high-confidence miR-340 targets in melanoma. Blue circle: mRNAs upregulated obtained from miR-340 inhibition experiments. Red circle: mRNAs downregulated from miR-340 <t>overexpression.</t> Green circle: mRNAs that directly interact with miR-340 identified from Bi-miR-340 experiments. In the center are overlapping targets from each of the datasets in bold, which are considered high-confidence direct miR340 targets.
    Pcmv Mir Control Microrna Overexpression Vectors, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcmv+mir+control/PCMVMIR+MicroRNA+Expression+Vector/pmc08858646-101-27-32
    Average 95 stars, based on 1 article reviews
    pcmv mir control microrna overexpression vectors - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    95
    OriGene control plasmids pcmv mir 216a
    Oncolytic activity of PD-H-375 against intra-abdominal growing CT-26 tumors. ( A ) Scheme of miR-375TS region within the genome of PD-H-375TS. Two copies of the miR-375TS, separated by a 6 nucleotide long spacer, were inserted into the 3′-UTR of PD-H 24 bp downstream of the 3D polymerase encoding sequence. The miR-375TS are 100% complementary to the pancreas-specific expressed miR-375. The sequence of miR-375TS is shown in capitals. ( B ) Silencing of PD-H-375TS by miR-375. HEK293T cells were transfected with <t>pCMV-miR-216a</t> or pCMV-miR-375 and infected 48 h later with 0.1 MOI PD-H-375TS. Twenty-four hours later virus titers were determined by plaque assay. Shown are mean values ± SEM from two experiments performed, each in triplicate. Significance: ** p < 0.01. ( C ) Comparison of PD-H-375TS and PD-H replication in CT-26Luc cells. HEK293T cells were seeded in 24-well plates and infected with PD-H or PD-H-375TS at an MOI of 1. Twenty four hours later the viruses were isolated and the virus titers determined by plaque assay. ( D ) Oncolytic activity of CVB3-PD-375TS in tumor model of i.p. growing CT-26Luc tumors. The 3 × 10 5 stable luciferase-expressing CT-26Luc cells were i,p. injected into Balb/C mice. At day 3, 4, and 5 after CT-26 tumor cell injection each 1 × 10 7 pfu PD-H-375TS ( n = 6) or PBS (control) were i.p, injected to mice. Luciferase expression was determined by bioluminescence imaging. The diagrams on the left show the luciferase activity on days 3 and 10 after CT-26Luc inoculation. Right: images of animals after application of luciferase at day 3 and 10 after tumor cell injection. * p < 0.05. ( E ) Kaplan–Meier survival curve. Significance: p = 0.0266.
    Control Plasmids Pcmv Mir 216a, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcmv+mir+control/PCMVMIR+MicroRNA+Expression+Vector/pmc08539752-88-18-21
    Average 95 stars, based on 1 article reviews
    control plasmids pcmv mir 216a - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    90
    Thermo Fisher pcmv-mir-control
    Oncolytic activity of PD-H-375 against intra-abdominal growing CT-26 tumors. ( A ) Scheme of miR-375TS region within the genome of PD-H-375TS. Two copies of the miR-375TS, separated by a 6 nucleotide long spacer, were inserted into the 3′-UTR of PD-H 24 bp downstream of the 3D polymerase encoding sequence. The miR-375TS are 100% complementary to the pancreas-specific expressed miR-375. The sequence of miR-375TS is shown in capitals. ( B ) Silencing of PD-H-375TS by miR-375. HEK293T cells were transfected with <t>pCMV-miR-216a</t> or pCMV-miR-375 and infected 48 h later with 0.1 MOI PD-H-375TS. Twenty-four hours later virus titers were determined by plaque assay. Shown are mean values ± SEM from two experiments performed, each in triplicate. Significance: ** p < 0.01. ( C ) Comparison of PD-H-375TS and PD-H replication in CT-26Luc cells. HEK293T cells were seeded in 24-well plates and infected with PD-H or PD-H-375TS at an MOI of 1. Twenty four hours later the viruses were isolated and the virus titers determined by plaque assay. ( D ) Oncolytic activity of CVB3-PD-375TS in tumor model of i.p. growing CT-26Luc tumors. The 3 × 10 5 stable luciferase-expressing CT-26Luc cells were i,p. injected into Balb/C mice. At day 3, 4, and 5 after CT-26 tumor cell injection each 1 × 10 7 pfu PD-H-375TS ( n = 6) or PBS (control) were i.p, injected to mice. Luciferase expression was determined by bioluminescence imaging. The diagrams on the left show the luciferase activity on days 3 and 10 after CT-26Luc inoculation. Right: images of animals after application of luciferase at day 3 and 10 after tumor cell injection. * p < 0.05. ( E ) Kaplan–Meier survival curve. Significance: p = 0.0266.
    Pcmv Mir Control, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcmv+mir+control/us11090313-909-34-43
    Average 90 stars, based on 1 article reviews
    pcmv-mir-control - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    95
    OriGene pcmv mir negative control vector
    Oncolytic activity of PD-H-375 against intra-abdominal growing CT-26 tumors. ( A ) Scheme of miR-375TS region within the genome of PD-H-375TS. Two copies of the miR-375TS, separated by a 6 nucleotide long spacer, were inserted into the 3′-UTR of PD-H 24 bp downstream of the 3D polymerase encoding sequence. The miR-375TS are 100% complementary to the pancreas-specific expressed miR-375. The sequence of miR-375TS is shown in capitals. ( B ) Silencing of PD-H-375TS by miR-375. HEK293T cells were transfected with <t>pCMV-miR-216a</t> or pCMV-miR-375 and infected 48 h later with 0.1 MOI PD-H-375TS. Twenty-four hours later virus titers were determined by plaque assay. Shown are mean values ± SEM from two experiments performed, each in triplicate. Significance: ** p < 0.01. ( C ) Comparison of PD-H-375TS and PD-H replication in CT-26Luc cells. HEK293T cells were seeded in 24-well plates and infected with PD-H or PD-H-375TS at an MOI of 1. Twenty four hours later the viruses were isolated and the virus titers determined by plaque assay. ( D ) Oncolytic activity of CVB3-PD-375TS in tumor model of i.p. growing CT-26Luc tumors. The 3 × 10 5 stable luciferase-expressing CT-26Luc cells were i,p. injected into Balb/C mice. At day 3, 4, and 5 after CT-26 tumor cell injection each 1 × 10 7 pfu PD-H-375TS ( n = 6) or PBS (control) were i.p, injected to mice. Luciferase expression was determined by bioluminescence imaging. The diagrams on the left show the luciferase activity on days 3 and 10 after CT-26Luc inoculation. Right: images of animals after application of luciferase at day 3 and 10 after tumor cell injection. * p < 0.05. ( E ) Kaplan–Meier survival curve. Significance: p = 0.0266.
    Pcmv Mir Negative Control Vector, supplied by OriGene, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/pcmv+mir+control/PCMVMIR+MicroRNA+Expression+Vector/pmc06759407-40-12-15
    Average 95 stars, based on 1 article reviews
    pcmv mir negative control vector - by Bioz Stars, 2026-10
    95/100 stars
      Buy from Supplier

    Image Search Results


    a. Experimental procedure for miFAST. Biotinylated miRNA mimics are transfected into cell cultures, and cellular lysates are isolated and separated into total input RNA and pull-down groups. Using IFAST, mRNAs associated with Bi-miR-340 and the RISC complex are extracted and RNA is prepared for analysis. b. Venn diagram of microarray datasets combined to determine high-confidence miR-340 targets in melanoma. Blue circle: mRNAs upregulated obtained from miR-340 inhibition experiments. Red circle: mRNAs downregulated from miR-340 overexpression. Green circle: mRNAs that directly interact with miR-340 identified from Bi-miR-340 experiments. In the center are overlapping targets from each of the datasets in bold, which are considered high-confidence direct miR340 targets.

    Journal: Molecular carcinogenesis

    Article Title: miFAST: a novel and rapid microRNA target capture method

    doi: 10.1002/mc.22780

    Figure Lengend Snippet: a. Experimental procedure for miFAST. Biotinylated miRNA mimics are transfected into cell cultures, and cellular lysates are isolated and separated into total input RNA and pull-down groups. Using IFAST, mRNAs associated with Bi-miR-340 and the RISC complex are extracted and RNA is prepared for analysis. b. Venn diagram of microarray datasets combined to determine high-confidence miR-340 targets in melanoma. Blue circle: mRNAs upregulated obtained from miR-340 inhibition experiments. Red circle: mRNAs downregulated from miR-340 overexpression. Green circle: mRNAs that directly interact with miR-340 identified from Bi-miR-340 experiments. In the center are overlapping targets from each of the datasets in bold, which are considered high-confidence direct miR340 targets.

    Article Snippet: Expression vectors and cell culture experiments miRZip TM scrambled hairpin RNA control and miRZip TM 340 microRNA inhibitor constructs (System Biosciences Inc., Mountain View, CA) were used to inhibit hsa-miR-340, and PCMV-MIR340 and PCMV-MIR control microRNA overexpression vectors (Origene, Rockville, MD) were used to overexpress hsa-miR-340.

    Techniques: Transfection, Isolation, Microarray, Inhibition, Over Expression

    Blue circle: 1,134 overexpressed mRNAs detected from the inhibition of miR-340 function. Red circle: 1,421 downregulated mRNAs detected from the overexpression of miR-340. Green circle: 922 mRNAs directly interacting with miR-340 detected using biotinylated miR-340. Overlapping blue and red circles: 30 targets in common between overexpressed mRNAs and downregulated mRNAs. Overlapping blue and green circles: 13 targets in common between overexpressed mRNAs and mRNAs directly interacting with miR-340. Overlapping red and green circles: 456 targets in common between downregulated mRNAs and mRNAs directly interacting with miR-340. Overlapping blue, red, and green circles: 23 targets in common between overexpressed mRNAs, downregulated mRNAs, and mRNAs directly interacting with miR-340.

    Journal: Molecular carcinogenesis

    Article Title: miFAST: a novel and rapid microRNA target capture method

    doi: 10.1002/mc.22780

    Figure Lengend Snippet: Blue circle: 1,134 overexpressed mRNAs detected from the inhibition of miR-340 function. Red circle: 1,421 downregulated mRNAs detected from the overexpression of miR-340. Green circle: 922 mRNAs directly interacting with miR-340 detected using biotinylated miR-340. Overlapping blue and red circles: 30 targets in common between overexpressed mRNAs and downregulated mRNAs. Overlapping blue and green circles: 13 targets in common between overexpressed mRNAs and mRNAs directly interacting with miR-340. Overlapping red and green circles: 456 targets in common between downregulated mRNAs and mRNAs directly interacting with miR-340. Overlapping blue, red, and green circles: 23 targets in common between overexpressed mRNAs, downregulated mRNAs, and mRNAs directly interacting with miR-340.

    Article Snippet: Expression vectors and cell culture experiments miRZip TM scrambled hairpin RNA control and miRZip TM 340 microRNA inhibitor constructs (System Biosciences Inc., Mountain View, CA) were used to inhibit hsa-miR-340, and PCMV-MIR340 and PCMV-MIR control microRNA overexpression vectors (Origene, Rockville, MD) were used to overexpress hsa-miR-340.

    Techniques: Inhibition, Over Expression

    a. Experimental procedure for miFAST. Biotinylated miRNA mimics are transfected into cell cultures, and cellular lysates are isolated and separated into total input RNA and pull-down groups. Using IFAST, mRNAs associated with Bi-miR-340 and the RISC complex are extracted and RNA is prepared for analysis. b. Venn diagram of microarray datasets combined to determine high-confidence miR-340 targets in melanoma. Blue circle: mRNAs upregulated obtained from miR-340 inhibition experiments. Red circle: mRNAs downregulated from miR-340 overexpression. Green circle: mRNAs that directly interact with miR-340 identified from Bi-miR-340 experiments. In the center are overlapping targets from each of the datasets in bold, which are considered high-confidence direct miR340 targets.

    Journal: Molecular carcinogenesis

    Article Title: miFAST: a novel and rapid microRNA target capture method

    doi: 10.1002/mc.22780

    Figure Lengend Snippet: a. Experimental procedure for miFAST. Biotinylated miRNA mimics are transfected into cell cultures, and cellular lysates are isolated and separated into total input RNA and pull-down groups. Using IFAST, mRNAs associated with Bi-miR-340 and the RISC complex are extracted and RNA is prepared for analysis. b. Venn diagram of microarray datasets combined to determine high-confidence miR-340 targets in melanoma. Blue circle: mRNAs upregulated obtained from miR-340 inhibition experiments. Red circle: mRNAs downregulated from miR-340 overexpression. Green circle: mRNAs that directly interact with miR-340 identified from Bi-miR-340 experiments. In the center are overlapping targets from each of the datasets in bold, which are considered high-confidence direct miR340 targets.

    Article Snippet: miRZip TM scrambled hairpin RNA control and miRZip TM 340 microRNA inhibitor constructs (System Biosciences Inc., Mountain View, CA) were used to inhibit hsa-miR-340, and PCMV-MIR340 and PCMV-MIR control microRNA overexpression vectors (Origene, Rockville, MD) were used to overexpress hsa-miR-340.

    Techniques: Transfection, Isolation, Microarray, Inhibition, Over Expression

    Blue circle: 1,134 overexpressed mRNAs detected from the inhibition of miR-340 function. Red circle: 1,421 downregulated mRNAs detected from the overexpression of miR-340. Green circle: 922 mRNAs directly interacting with miR-340 detected using biotinylated miR-340. Overlapping blue and red circles: 30 targets in common between overexpressed mRNAs and downregulated mRNAs. Overlapping blue and green circles: 13 targets in common between overexpressed mRNAs and mRNAs directly interacting with miR-340. Overlapping red and green circles: 456 targets in common between downregulated mRNAs and mRNAs directly interacting with miR-340. Overlapping blue, red, and green circles: 23 targets in common between overexpressed mRNAs, downregulated mRNAs, and mRNAs directly interacting with miR-340.

    Journal: Molecular carcinogenesis

    Article Title: miFAST: a novel and rapid microRNA target capture method

    doi: 10.1002/mc.22780

    Figure Lengend Snippet: Blue circle: 1,134 overexpressed mRNAs detected from the inhibition of miR-340 function. Red circle: 1,421 downregulated mRNAs detected from the overexpression of miR-340. Green circle: 922 mRNAs directly interacting with miR-340 detected using biotinylated miR-340. Overlapping blue and red circles: 30 targets in common between overexpressed mRNAs and downregulated mRNAs. Overlapping blue and green circles: 13 targets in common between overexpressed mRNAs and mRNAs directly interacting with miR-340. Overlapping red and green circles: 456 targets in common between downregulated mRNAs and mRNAs directly interacting with miR-340. Overlapping blue, red, and green circles: 23 targets in common between overexpressed mRNAs, downregulated mRNAs, and mRNAs directly interacting with miR-340.

    Article Snippet: miRZip TM scrambled hairpin RNA control and miRZip TM 340 microRNA inhibitor constructs (System Biosciences Inc., Mountain View, CA) were used to inhibit hsa-miR-340, and PCMV-MIR340 and PCMV-MIR control microRNA overexpression vectors (Origene, Rockville, MD) were used to overexpress hsa-miR-340.

    Techniques: Inhibition, Over Expression

    Oncolytic activity of PD-H-375 against intra-abdominal growing CT-26 tumors. ( A ) Scheme of miR-375TS region within the genome of PD-H-375TS. Two copies of the miR-375TS, separated by a 6 nucleotide long spacer, were inserted into the 3′-UTR of PD-H 24 bp downstream of the 3D polymerase encoding sequence. The miR-375TS are 100% complementary to the pancreas-specific expressed miR-375. The sequence of miR-375TS is shown in capitals. ( B ) Silencing of PD-H-375TS by miR-375. HEK293T cells were transfected with pCMV-miR-216a or pCMV-miR-375 and infected 48 h later with 0.1 MOI PD-H-375TS. Twenty-four hours later virus titers were determined by plaque assay. Shown are mean values ± SEM from two experiments performed, each in triplicate. Significance: ** p < 0.01. ( C ) Comparison of PD-H-375TS and PD-H replication in CT-26Luc cells. HEK293T cells were seeded in 24-well plates and infected with PD-H or PD-H-375TS at an MOI of 1. Twenty four hours later the viruses were isolated and the virus titers determined by plaque assay. ( D ) Oncolytic activity of CVB3-PD-375TS in tumor model of i.p. growing CT-26Luc tumors. The 3 × 10 5 stable luciferase-expressing CT-26Luc cells were i,p. injected into Balb/C mice. At day 3, 4, and 5 after CT-26 tumor cell injection each 1 × 10 7 pfu PD-H-375TS ( n = 6) or PBS (control) were i.p, injected to mice. Luciferase expression was determined by bioluminescence imaging. The diagrams on the left show the luciferase activity on days 3 and 10 after CT-26Luc inoculation. Right: images of animals after application of luciferase at day 3 and 10 after tumor cell injection. * p < 0.05. ( E ) Kaplan–Meier survival curve. Significance: p = 0.0266.

    Journal: Viruses

    Article Title: Application Route and Immune Status of the Host Determine Safety and Oncolytic Activity of Oncolytic Coxsackievirus B3 Variant PD-H

    doi: 10.3390/v13101918

    Figure Lengend Snippet: Oncolytic activity of PD-H-375 against intra-abdominal growing CT-26 tumors. ( A ) Scheme of miR-375TS region within the genome of PD-H-375TS. Two copies of the miR-375TS, separated by a 6 nucleotide long spacer, were inserted into the 3′-UTR of PD-H 24 bp downstream of the 3D polymerase encoding sequence. The miR-375TS are 100% complementary to the pancreas-specific expressed miR-375. The sequence of miR-375TS is shown in capitals. ( B ) Silencing of PD-H-375TS by miR-375. HEK293T cells were transfected with pCMV-miR-216a or pCMV-miR-375 and infected 48 h later with 0.1 MOI PD-H-375TS. Twenty-four hours later virus titers were determined by plaque assay. Shown are mean values ± SEM from two experiments performed, each in triplicate. Significance: ** p < 0.01. ( C ) Comparison of PD-H-375TS and PD-H replication in CT-26Luc cells. HEK293T cells were seeded in 24-well plates and infected with PD-H or PD-H-375TS at an MOI of 1. Twenty four hours later the viruses were isolated and the virus titers determined by plaque assay. ( D ) Oncolytic activity of CVB3-PD-375TS in tumor model of i.p. growing CT-26Luc tumors. The 3 × 10 5 stable luciferase-expressing CT-26Luc cells were i,p. injected into Balb/C mice. At day 3, 4, and 5 after CT-26 tumor cell injection each 1 × 10 7 pfu PD-H-375TS ( n = 6) or PBS (control) were i.p, injected to mice. Luciferase expression was determined by bioluminescence imaging. The diagrams on the left show the luciferase activity on days 3 and 10 after CT-26Luc inoculation. Right: images of animals after application of luciferase at day 3 and 10 after tumor cell injection. * p < 0.05. ( E ) Kaplan–Meier survival curve. Significance: p = 0.0266.

    Article Snippet: HEK293T cells were seeded and transfected the next day, when they reached a confluence of 60% with the control plasmids pCMV-miR-216a (Origene Technologies, Rockville, MD, USA), expressing the miR-216a or pCMV-miR-375 (Origene Technologies) expressing the miR-375, each with PEI Max transfection reagent.

    Techniques: Activity Assay, Sequencing, Transfection, Infection, Virus, Plaque Assay, Comparison, Isolation, Luciferase, Expressing, Injection, Control, Imaging